BBIO logo

BridgeBio Pharma (BBIO) Net income

annual net income:

-$535.76M+$107.44M(+16.70%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BBIO annual net profit is -$535.76 million, with the most recent change of +$107.44 million (+16.70%) on December 31, 2024.
  • During the last 3 years, BBIO annual net income has risen by +$26.78 million (+4.76%).
  • BBIO annual net income is now -1652.86% below its all-time high of -$30.57 million, reached on December 31, 2017.

Performance

BBIO Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

quarterly net income:

-$167.42M+$97.63M(+36.83%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO quarterly net profit is -$167.42 million, with the most recent change of +$97.63 million (+36.83%) on March 31, 2025.
  • Over the past year, BBIO quarterly net income has dropped by -$132.21 million (-375.41%).
  • BBIO quarterly net income is now -1598.68% below its all-time high of -$9.86 million, reached on June 30, 2022.

Performance

BBIO quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

TTM net income:

-$667.97M-$132.21M(-24.68%)
March 31, 2025

Summary

  • As of today (May 29, 2025), BBIO TTM net profit is -$667.97 million, with the most recent change of -$132.21 million (-24.68%) on March 31, 2025.
  • Over the past year, BBIO TTM net income has dropped by -$129.71 million (-24.10%).
  • BBIO TTM net income is now -1855.64% below its all-time high of -$34.16 million, reached on March 31, 2018.

Performance

BBIO TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBBIOincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

BBIO Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.7%-375.4%-24.1%
3 y3 years+4.8%+14.8%-12.1%
5 y5 years-105.6%-82.3%-129.3%

BBIO Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-11.3%+16.7%-1598.7%+36.8%-57.2%at low
5 y5-year-105.6%+16.7%-1598.7%+36.8%-129.3%at low
alltimeall time-1652.9%+16.7%-1598.7%+36.8%-1855.6%at low

BBIO Net income History

DateAnnualQuarterlyTTM
Mar 2025
-
-$167.42M(-36.8%)
-$667.97M(+24.7%)
Dec 2024
-$535.76M(-16.7%)
-$265.05M(+63.6%)
-$535.76M(+22.1%)
Sep 2024
-
-$162.04M(+120.6%)
-$438.86M(-3.3%)
Jun 2024
-
-$73.46M(+108.6%)
-$453.82M(-15.7%)
Mar 2024
-
-$35.22M(-79.1%)
-$538.26M(-16.3%)
Dec 2023
-$643.20M(+33.7%)
-$168.15M(-5.0%)
-$643.20M(+5.0%)
Sep 2023
-
-$177.00M(+12.1%)
-$612.64M(+6.9%)
Jun 2023
-
-$157.90M(+12.7%)
-$572.99M(+34.8%)
Mar 2023
-
-$140.16M(+1.9%)
-$424.94M(-11.7%)
Dec 2022
-$481.18M(-14.5%)
-$137.59M(+0.2%)
-$481.18M(-2.0%)
Sep 2022
-
-$137.34M(+1293.5%)
-$490.77M(-3.7%)
Jun 2022
-
-$9.86M(-95.0%)
-$509.37M(-14.5%)
Mar 2022
-
-$196.40M(+33.4%)
-$595.86M(+5.9%)
Dec 2021
-$562.54M
-$147.18M(-5.6%)
-$562.54M(+5.1%)
Sep 2021
-
-$155.94M(+61.8%)
-$535.34M(+8.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$96.35M(-40.9%)
-$495.27M(-4.7%)
Mar 2021
-
-$163.08M(+35.9%)
-$519.95M(+15.9%)
Dec 2020
-$448.72M(+72.2%)
-$119.98M(+3.6%)
-$448.72M(+11.6%)
Sep 2020
-
-$115.86M(-4.3%)
-$402.20M(+16.1%)
Jun 2020
-
-$121.03M(+31.8%)
-$346.32M(+18.9%)
Mar 2020
-
-$91.85M(+25.0%)
-$291.25M(+11.8%)
Dec 2019
-$260.59M(+99.3%)
-$73.46M(+22.5%)
-$260.59M(+15.4%)
Sep 2019
-
-$59.98M(-9.1%)
-$225.77M(+14.5%)
Jun 2019
-
-$65.96M(+7.8%)
-$197.19M(+25.0%)
Mar 2019
-
-$61.19M(+58.3%)
-$157.78M(+20.7%)
Dec 2018
-$130.75M(+327.8%)
-$38.64M(+23.1%)
-$130.75M(+42.0%)
Sep 2018
-
-$31.40M(+18.3%)
-$92.11M(+51.7%)
Jun 2018
-
-$26.55M(-22.3%)
-$60.71M(+77.7%)
Mar 2018
-
-$34.16M
-$34.16M
Dec 2017
-$30.57M
-
-

FAQ

  • What is BridgeBio Pharma annual net profit?
  • What is the all time high annual net income for BridgeBio Pharma?
  • What is BridgeBio Pharma annual net income year-on-year change?
  • What is BridgeBio Pharma quarterly net profit?
  • What is the all time high quarterly net income for BridgeBio Pharma?
  • What is BridgeBio Pharma quarterly net income year-on-year change?
  • What is BridgeBio Pharma TTM net profit?
  • What is the all time high TTM net income for BridgeBio Pharma?
  • What is BridgeBio Pharma TTM net income year-on-year change?

What is BridgeBio Pharma annual net profit?

The current annual net income of BBIO is -$535.76M

What is the all time high annual net income for BridgeBio Pharma?

BridgeBio Pharma all-time high annual net profit is -$30.57M

What is BridgeBio Pharma annual net income year-on-year change?

Over the past year, BBIO annual net profit has changed by +$107.44M (+16.70%)

What is BridgeBio Pharma quarterly net profit?

The current quarterly net income of BBIO is -$167.42M

What is the all time high quarterly net income for BridgeBio Pharma?

BridgeBio Pharma all-time high quarterly net profit is -$9.86M

What is BridgeBio Pharma quarterly net income year-on-year change?

Over the past year, BBIO quarterly net profit has changed by -$132.21M (-375.41%)

What is BridgeBio Pharma TTM net profit?

The current TTM net income of BBIO is -$667.97M

What is the all time high TTM net income for BridgeBio Pharma?

BridgeBio Pharma all-time high TTM net profit is -$34.16M

What is BridgeBio Pharma TTM net income year-on-year change?

Over the past year, BBIO TTM net profit has changed by -$129.71M (-24.10%)
On this page